A major analysis of over 1.2 million medical records linked diabetes and weight loss drugs such as Ozempic and Wegovy to reduced risks of mental health conditions including alcohol, cannabis, and opioid use disorders, along with suicidal thoughts, schizophrenia, and dementia. Researchers caution that while findings show a statistically significant connection, definitive claims should not yet be made. The drugs act on brain receptors involved in appetite and addiction control, showcasing potential benefits beyond weight management but also noting common side effects like nausea and more severe risks to pancreatitis and kidney function.
The study indicates that diabetes medications like Ozempic and Wegovy may help reduce the risk of various mental health and addiction disorders.
Researchers found these GLP-1 receptor agonists could lower the risk of suicidal thoughts by 10%, schizophrenia by 18%, and dementia by 12%.
Collection
[
|
...
]